Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
Authors
Keywords
-
Journal
BMC INFECTIOUS DISEASES
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-08-19
DOI
10.1186/1471-2334-13-380
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
- (2012) Giulia Vicari et al. CLINICAL INFECTIOUS DISEASES
- High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
- (2012) L. Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
- (2011) J. M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Colistin pharmacokinetics: the fog is lifting
- (2011) W. Couet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin: new lessons on an old antibiotic
- (2011) D. Yahav et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
- (2010) C. A. DeRyke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiresistant Acinetobacter baumannii infections: epidemiology and management
- (2010) José Garnacho-Montero et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Risk factors for colistin-associated nephrotoxicity
- (2010) Pinyo Rattanaumpawan et al. JOURNAL OF INFECTION
- Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin
- (2010) Hee ja Ko et al. NEPHRON CLINICAL PRACTICE
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
- (2009) Joshua D. Hartzell et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections
- (2009) M. Montero et al. INFECTION
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
- (2008) Nikolaos Markou et al. CLINICAL THERAPEUTICS
- The RIFLE criteria and mortality in acute kidney injury: A systematic review
- (2007) Z. Ricci et al. KIDNEY INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started